Table of Contents
The White House has directed HHS and NIH, along with every other federal department and agency, to realign fiscal 2028 research and development budgets around nine priority areas, including AI and foundational biological sciences, establishing new White House AI research priorities that will shape federal science funding for years to come.
The Scope of These White House AI Research Priorities
The order applies governmentwide, not just to health agencies, but its guidance on foundational biological sciences and AI carries the most direct stakes for NIH and the broader biomedical research pipeline hospitals and health systems depend on.
The Memo and Its Accompanying Report
The July 21 memo accompanies a broader Office of Science and Technology Policy report, “Science: A New Golden Age,” which Director Michael Kratsios called the first comprehensive rewrite of U.S. science policy in more than 80 years. He said the plan positions the country to lead the AI-driven scientific revolution that will define the next century.
How These White House AI Research Priorities Affect NIH
Agencies with broad life-sciences missions, including NIH, are told to prioritize foundational research in the biological sciences over the wider “life sciences” category, and to treat the Genesis Mission, the AI-for-science initiative President Trump launched in November 2025 to double U.S. research productivity within a decade, as a central budget priority.
A Notable Shift Toward Foundational Biology
This directive to prioritize foundational biological sciences specifically, rather than the broader life sciences category, suggests the administration wants NIH to concentrate resources on more basic, mechanistic research rather than spreading funding across the full breadth of applied and translational life sciences work.
Funding Mechanism Reforms Within These White House AI Research Priorities
The memo also pushes agencies toward longer research grants of five years or more, citing the NIH Director’s Pioneer Award as a model, and toward faster, lower-friction “fast grants” for exploratory work.
Why Longer Grant Cycles Matter
Citing the Pioneer Award, which has historically supported high-risk, high-reward research over extended timeframes, as a model for broader grant reform signals an intent to reduce the administrative burden and short-term funding pressure that researchers often cite as obstacles to pursuing more ambitious, longer-term scientific questions.
Implementation Timeline for These White House AI Research Priorities
Every federal agency with at least $3 billion in fiscal year 2026 R&D budget authority must submit a plan to Kratsios and Russ Vought, director of the Office of Management and Budget, within 90 days detailing how it will implement the memo’s funding-mechanism and talent reforms.
What This Deadline Means for Agencies
This 90-day window gives NIH and other large research agencies a relatively short timeframe to develop concrete implementation plans, suggesting the administration wants to move quickly from policy directive to actionable budget changes ahead of the fiscal 2028 cycle.
What This Means for Hospitals and the Biomedical Research Pipeline
Given that NIH funding underpins much of the biomedical research that eventually informs clinical practice at hospitals and health systems, these White House AI research priorities could meaningfully reshape which types of research receive federal support in the coming years, with AI and foundational biology positioned to capture a growing share of available funding.
What to Watch Going Forward
As NIH and other affected agencies prepare their required implementation plans over the next 90 days, healthcare and research institutions will likely watch closely for specifics on how funding priorities shift in practice, particularly whether the emphasis on AI and foundational biological sciences comes at the expense of other research categories that hospitals and health systems have historically relied on for federal grant support.
How This Fits Into the Broader Genesis Mission Strategy
This directive builds directly on HHS’s own recent announcement of its participation in the Genesis Mission through the NIH-led Bio Genesis Mission, which aims to use AI and advanced computing to cut in half the time it takes for scientific discoveries to reach patients.
Read together, the two announcements suggest a coordinated push across the administration: while HHS’s Bio Genesis Mission effort outlines specific research challenges around chronic disease, pediatric cancer, and drug discovery, this broader White House memo now requires that funding priority to be reflected concretely in NIH’s fiscal 2028 budget planning. That alignment between programmatic announcement and budgetary mandate suggests the administration intends for AI-driven biomedical research to move quickly from stated priority to funded reality, rather than remaining a rhetorical commitment without corresponding resource allocation.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
